Rate of Percutaneous Coronary Intervention for the Management of Acute Coronary Syndromes and Stable Coronary Artery Disease in the United States (2007 to 2011)

Patel, 2009, J Am Coll Cardiol, 53, 530, 10.1016/j.jacc.2008.10.005

Chan, 2011, Appropriateness of percutaneous coronary intervention, JAMA, 306, 53

Hannan, 2012, Appropriateness of coronary revascularization for patients without acute coronary syndromes, J Am Coll Cardiol, 59, 1870, 10.1016/j.jacc.2012.01.050

Boden, 2007, Optimal medical therapy with or without PCI for stable coronary disease, N Engl J Med, 356, 1503, 10.1056/NEJMoa070829

2007

Mohan AV, Fazel R, Huang PH, Shen YC, Howard D. Changes in geographic variation in the use of percutaneous coronary intervention for stable ischemic heart disease after publication of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Circ Cardiovasc Qual Outcomes 2014;7:125–130.

Elixhauser, 1998, Comorbidity measures for use with administrative data, Med Care, 36, 8, 10.1097/00005650-199801000-00004

U.S. Department of Commerce. United States Census Bureau. Available at: http://www.census.gov/popest/data/national/totals/2012/index.html. Accessed on January 19, 2014.

Ahmed, 2011, Recent changes in practice of elective percutaneous coronary intervention for stable angina, Circ Cardiovasc Qual Outcomes, 4, 300, 10.1161/CIRCOUTCOMES.110.957175

McNulty, 2011, A brave new world? Measuring trends in percutaneous coronary intervention for stable angina after COURAGE, Circ Cardiovasc Qual Outcomes, 4, 263, 10.1161/CIRCOUTCOMES.111.961144

Atwater, 2009, The immediate impact of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial on the management of stable angina, Clin Cardiol, 32, E1, 10.1002/clc.20524

Borden, 2011, Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention, JAMA, 305, 1882, 10.1001/jama.2011.601

Ford, 2007, Explaining the decrease in U.S. deaths from coronary disease, 1980–2000, N Engl J Med, 356, 2388, 10.1056/NEJMsa053935

Ryan, 2009, Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the U.S. Medicare program, Circulation, 119, 952, 10.1161/CIRCULATIONAHA.108.781138

Epstein, 2011, Coronary revascularization trends in the United States, 2001-2008, JAMA, 305, 1769, 10.1001/jama.2011.551

Hodgson, 2007, Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-eluting Stent Task Force, Catheter Cardiovasc Interv, 69, 327, 10.1002/ccd.21093

Tonino, 2009, Fractional flow reserve versus angiography for guiding percutaneous coronary intervention, N Engl J Med, 360, 213, 10.1056/NEJMoa0807611

Chan, 2013, Patient and hospital characteristics associated with inappropriate percutaneous coronary interventions, J Am Coll Cardiol, 62, 2274, 10.1016/j.jacc.2013.07.086

Kiyota, 2004, Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records, Am Heart J, 148, 99, 10.1016/j.ahj.2004.02.013

Petersen, 1999, Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database, J Gen Intern Med, 14, 555, 10.1046/j.1525-1497.1999.10198.x